Cigna Group (CI) Competitors $302.92 -0.35 (-0.12%) Closing price 03:59 PM EasternExtended Trading$303.34 +0.43 (+0.14%) As of 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CI vs. CNC, ELV, HCA, HUM, UNH, MOH, SEM, JYNT, AEMD, and ABBVShould you be buying Cigna Group stock or one of its competitors? The main competitors of Cigna Group include Centene (CNC), Elevance Health (ELV), HCA Healthcare (HCA), Humana (HUM), UnitedHealth Group (UNH), Molina Healthcare (MOH), Select Medical (SEM), Joint (JYNT), Aethlon Medical (AEMD), and AbbVie (ABBV). These companies are all part of the "medical" sector. Cigna Group vs. Its Competitors Centene Elevance Health HCA Healthcare Humana UnitedHealth Group Molina Healthcare Select Medical Joint Aethlon Medical AbbVie Centene (NYSE:CNC) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends. Do insiders and institutionals believe in CNC or CI? 93.6% of Centene shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.4% of Centene shares are owned by insiders. Comparatively, 0.7% of Cigna Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is CNC or CI more profitable? Centene has a net margin of 2.04% compared to Cigna Group's net margin of 1.97%. Cigna Group's return on equity of 18.63% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene2.04% 14.56% 4.75% Cigna Group 1.97%18.63%4.97% Do analysts prefer CNC or CI? Centene currently has a consensus target price of $64.75, indicating a potential upside of 111.53%. Cigna Group has a consensus target price of $380.39, indicating a potential upside of 25.58%. Given Centene's higher possible upside, equities research analysts clearly believe Centene is more favorable than Cigna Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 0 Sell rating(s) 12 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33Cigna Group 0 Sell rating(s) 2 Hold rating(s) 16 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, CNC or CI? Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$169.28B0.09$3.31B$6.714.56Cigna Group$247.12B0.33$3.43B$18.0616.77 Which has more volatility and risk, CNC or CI? Centene has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Comparatively, Cigna Group has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Does the media favor CNC or CI? In the previous week, Centene had 35 more articles in the media than Cigna Group. MarketBeat recorded 67 mentions for Centene and 32 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.25 beat Centene's score of 0.03 indicating that Cigna Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 9 Very Positive mention(s) 4 Positive mention(s) 40 Neutral mention(s) 9 Negative mention(s) 3 Very Negative mention(s) Neutral Cigna Group 27 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCigna Group beats Centene on 12 of the 16 factors compared between the two stocks. Get Cigna Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CI vs. The Competition Export to ExcelMetricCigna GroupMED IndustryMedical SectorNYSE ExchangeMarket Cap$80.92B$40.98B$5.53B$20.66BDividend Yield1.99%101.64%5.06%3.71%P/E Ratio16.778.9628.5827.83Price / Sales0.330.76372.6456.10Price / Cash8.028.9124.7217.94Price / Book2.042.618.234.60Net Income$3.43B$2.64B$3.19B$989.58M7 Day Performance-3.33%-2.89%5.46%1.16%1 Month Performance-4.45%-13.22%9.39%5.49%1 Year Performance-9.52%-34.98%30.48%10.60% Cigna Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CICigna Group4.9985 of 5 stars$302.92-0.1%$380.39+25.6%-9.6%$80.92B$247.12B16.7773,500Positive NewsCNCCentene4.9797 of 5 stars$33.06-0.8%$68.87+108.3%-53.7%$16.45B$163.07B4.9360,500Trending NewsAnalyst ForecastHigh Trading VolumeELVElevance Health4.9601 of 5 stars$346.76-0.3%$498.87+43.9%-36.5%$78.34B$177.01B13.53104,200Upcoming EarningsAnalyst ForecastHCAHCA Healthcare4.8985 of 5 stars$378.51+0.5%$395.71+4.5%+15.9%$91.06B$70.60B16.83316,000HUMHumana4.5274 of 5 stars$237.00-1.1%$280.76+18.5%-39.7%$28.60B$117.76B16.7665,680Analyst DowngradeUNHUnitedHealth Group4.997 of 5 stars$303.75-1.6%$415.57+36.8%-40.6%$275.54B$400.28B12.72400,000Positive NewsUpcoming EarningsMOHMolina Healthcare4.988 of 5 stars$233.14-2.7%$364.21+56.2%-24.7%$12.64B$40.65B11.2618,000Analyst ForecastSEMSelect Medical5 of 5 stars$14.83-2.0%$26.00+75.3%-60.7%$1.91B$5.19B11.0744,100JYNTJoint3.3384 of 5 stars$11.83+1.2%$15.50+31.0%-15.8%$181.00M$51.90M-20.40320AEMDAethlon Medical1.8925 of 5 stars$1.15-7.3%$56.00+4,769.6%-65.3%$2.98M$570K-0.0910ABBVAbbVie4.8089 of 5 stars$187.44-1.0%$211.29+12.7%+12.9%$331.09B$56.33B79.7655,000Positive News Related Companies and Tools Related Companies Centene Alternatives Elevance Health Alternatives HCA Healthcare Alternatives Humana Alternatives UnitedHealth Group Alternatives Molina Healthcare Alternatives Select Medical Alternatives Joint Alternatives Aethlon Medical Alternatives AbbVie Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CI) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cigna Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Cigna Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
